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Abstract
Purpose Preference-based measures are essential for producing quality-adjusted life years (QALYs) that are widely used 
for economic evaluations. In the absence of such measures, mapping algorithms can be applied to estimate utilities from 
disease-specific measures. This paper aims to develop mapping algorithms between the MacNew Heart Disease Quality of 
Life Questionnaire (MacNew) instrument and the English and the US-based EQ-5D-5L value sets.
Methods Individuals with heart disease were recruited from six countries: Australia, Canada, Germany, Norway, UK and 
the US in 2011/12. Both parametric and non-parametric statistical techniques were applied to estimate mapping algorithms 
that predict utilities for MacNew scores from EQ-5D-5L value sets. The optimal algorithm for each country-specific value 
set was primarily selected based on root mean square error (RMSE), mean absolute error (MAE), concordance correlation 
coefficient (CCC), and r-squared. Leave-one-out cross-validation was conducted to test the generalizability of each model.
Results For both the English and the US value sets, the one-inflated beta regression model consistently performed best in 
terms of all criteria. Similar results were observed for the cross-validation results. The preferred model explained 59 and 
60% for the English and the US value set, respectively. Linear equating provided predicted values that were equivalent to 
observed values.
Conclusions The preferred mapping function enables to predict utilities for MacNew data from the EQ-5D-5L value sets 
recently developed in England and the US with better accuracy. This allows studies, which have included the MacNew to be 
used in cost-utility analyses and thus, the comparison of services with interventions across the health system.
Keywords MacNew · EQ-5D-5L · Economic evaluation · Mapping · QALY · Utility · Heart disease
JEL Classification I1 · C1
Introduction
Coronary heart disease (CHD) is the leading cause of death 
and disability worldwide, particularly in Western countries. 
The total number of deaths from CHD increased by 19% over 
the most recent decade, from 7.96 million deaths in 2006 to 
9.48 million deaths in 2016 [1]. The rising prevalence of 
CHD deaths will lead to increased demand for healthcare ser-
vices. Resources for the prevention and treatment of CHD are 
limited and compete with demands from other disease areas 
and uses [2]. Consequently, there is a need for evaluating the 
cost-effectiveness of CHD interventions as compared to the 
competing use of resources in other disease groups.
In the cost-effectiveness appraisal of competing health-
care programmes across disease areas, there is a growing 
interest in estimating health outcomes on a generic metric, 
such as quality-adjusted life years (QALYs) [3]. To obtain 
the quality adjustment weight in the QALY, generic pref-
erence-based measures are used [4]. In many clinical trials, 
however, condition- or disease-specific non-preference-based 
measures commonly applied. This is mainly because these 
measures tend to identify disease-specific changes in health 
that might not be picked up by generic preference-based 
measures, though they may miss side effects and the impact 
on possible co-morbidities [3, 11]. Thus, in the absence of 
preference-based measures, the second-best alternative is to 
‘crosswalk’, or ‘map’, disease-specific scores onto generic 
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preference-based values to express health improvements in 
terms of QALY, which allows cross-study comparability.
Condition- or disease-specific measures assess the special 
states and concerns of diagnostic groups. The self-adminis-
tered MacNew Heart Disease Quality of life Questionnaire 
(MacNew) is designed to evaluate how daily activities and 
physical, emotional, and social functioning are affected by 
CHD and its treatment [5]. CHD can last for longer peri-
ods and re-occur, impairing the ability to cope with daily 
life. While MacNew is suitable to measure CHD impact, 
it does not produce utility. In contrast, generic preference-
based measures provide a utility weight for calculating 
QALY, which is useful for economic evaluations. Among 
preference-based measures, the EuroQoL five-dimensional 
questionnaire (EQ-5D) [8] is the most widely applied in 
cost-effectiveness analyses. The EQ-5D is also the preferred 
measure of the quality of life for health technology assess-
ment in many European countries [6]. Such measures pro-
vide valuations on a 0 (being dead) to 1 (full health) scale. 
Health states valued less than 0 are also allowed. Two ver-
sions of EQ5D are available: the three-level (3L) and five-
level (5L). The 5L is the modified version of 3L by adding 
two severity levels to address the ceiling and sensitivity con-
cerns with the earlier 3L version [7]. Recently, 5L value sets 
are being developed in many countries [8, 9].
The MacNew has been mapped to the EQ-5D and other 
generic preference-based instruments [2]. However, the 
EQ-5D in the previous study was based on an interim value 
set, which was a ‘crosswalk’ between the earlier 3L version 
and the revised 5L descriptive system [10]. Thus, a revised 
mapping algorithm may be required with the publication of 
the directly elicited EQ-5D-5L value sets.
Studies revealed that regression-based mapping 
approaches usually under-predict high scores and over-
predict low scores, because of regression to the mean [11]. 
Regression to the mean also expected to produce predicted 
values from mapping functions that have lower levels of 
variance than observed values [11, 12]. Thus, Fayers and 
Hays [12] have suggested the use of linking strategies such 
as simple linear equating, equipercentile equating, and 
item-response theory (IRT) methodologies as alternatives. 
While regression-based models attempt to predict the most 
likely true preference-based value set using the profile-
based score, linking try to find the preference-based value 
set that is equivalent to the profile-based score by aligning 
the score distributions of the two scales [12]. Few map-
ping studies had applied regression-based approaches in 
combination with scale aligning; i.e., they first predicted 
utility, and then applied scale aligning between predicted 
and observed values [13, 14]. In the present study, a similar 
approach has been followed—first obtained predicted value 
sets via regression-based techniques and then used simple 
linear equating to force the predicted values to have the same 
mean and variance as the observed value sets.
In general, the objective of this study was to estimate the 
EQ-5D-5L value sets from the MacNew profile measure. 
More specifically, this paper has three important motiva-
tions. First, to update the existing mapping algorithms for 
MacNew that was recently published [2] using the directly 
elicited EQ-5D-5L value sets. Second, to examine whether 
mapping algorithms for the MacNew differ across countries, 
by employing two country-specific health state preferences; 
i.e., EQ-5D-5L value sets for the English and the US (United 
States). Lastly, this study makes important methodological 
contributions by investigating the relative merits of five 
regression models, and eventually linearly aligning the pre-
dicted values along the observed scales. Best practice for 
the reporting of mapping studies are followed, in line with 




Data were obtained from a large international Multi-Instru-
ment Comparison (MIC) study, which includes both EQ-
5D-5L, and MacNew in addition to other instruments. The 
MIC study was an online survey administered in six coun-
tries in 2011/12: Australia, Canada, Germany, Norway, UK, 
and the US. Among the disease groups included in this com-
prehensive international study, the current paper is based on 
the CHD group (n = 943). There was no missing information 
on the data used in this study. However, considering the lack 
of direct control in the online survey, several edit procedures 
such as a comparison of duplicated questions, and removal 
of respondents whose recorded completion time shorter than 
20 min were conducted to ensure the quality of data. For 
further details on data and respondent recruitment, see Chen 
et al. [2] and Richardson et al. [16].
Measures of variables
The EQ-5D-5L consists of five dimensions each with five 
severity levels. The dimensions include mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression, 
while the five severity levels constitute no problems, slight 
problems, moderate problems, severe problems and unable 
to/extreme problems. In this paper, the directly elicited 
EQ-5D-5L value sets from two countries (England, and the 
US) were applied [17, 18]. Both the English and the US 
value sets were published based on the EQ-VT approach. 
The scale length is quite different for the two countries: the 
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worst health state or the ‘pits’ (55555) equals − 0.285 for 
the English value set and − 0.573 for the US.
The MacNew is designed to assess the patient’s feelings 
about how CHD affects daily functioning and contains 27 
items, each with a seven-point Likert scale in decreasing 
severity [19]. Responses can be combined and a global 
health-related quality of life score was calculated as the 
average of the 27 item scores. The MacNew also cov-
ers three-domain scales: physical limitation domain scale 
(13-items), emotional function domain scale (14-items), 
and social function domain scale (13-items). Each domain 
includes overlapping items. The total score for each domain 
was calculated by summing responses across all items in that 
domain. Finally, each subscale summary scores were linearly 
transformed onto a 0–1 scale; 0 indicating the worst; and 1 
the best possible health state [20].
Statistical analyses and estimation
Exploratory data analysis
The precision of the mapping approaches relies on the extent 
of overlapping between the source and target instruments 
[11]. The Spearman’s rank correlations (ρ) between the 
MacNew domain scales and the EQ-5D-5L value sets were 
evaluated with a 95% confidence interval (CI) computed 
using 1000 bootstrap iterations.
Exploratory factor analysis (EFA) was also conducted to 
understand if the MacNew domain scales and EQ-5D-5L 
dimensions could be described by the same latent constructs 
or factors. The EFA was employed using iterated princi-
pal factors, which has been recommended as the preferred 
method of factor extraction [21]. An eigenvalue greater than 
1 and the scree plot test were used as factor retention criteria 
[22, 23]. Although there is no consensus on a single standard 
threshold, factor loadings of 0.40 and above were consid-
ered “meaningful”, or at least salient [24], suggesting that 
MacNew domain scales and EQ-5D-5L dimensions were 
capturing the same underlying construct. Oblique-promax 
rotation of factors was applied to allow for a possible cor-
relation between extracted factors.
Regression analysis
A direct mapping technique was applied by regressing the 
EQ-5D-5L value set onto the MacNew domain scores, such 
as physical, emotional and social. The squared term of each 
domain was explored. Furthermore, age and gender were 
considered as covariates to make mapping equations appli-
cable to all datasets.
Here, five regression methods have been considered, as 
there was no single gold standard algorithm that would best 
predict the EQ-5D-5L value sets: ordinary least squares (OLS), 
generalized linear model (GLM), one-inflated beta (OIB) 
regression, fractional regression model (FRM), and robust 
MM-estimator (MM). In each regression model, the final pre-
dictors were retained only when they were statistically signifi-
cant (i.e. p < 0.05). Predictors were also required to be logically 
consistent: poorer scores on a source instrument should lead 
to lower utility on the target instrument. Squared-terms were 
only considered if linear terms significantly contributed to the 
model.
OLS was considered, as it is the most commonly used 
method in mapping literature [11]. The GLM is a flexible gen-
eralization of OLS that allows our target variable (1) to have 
a non-normal error distribution, and; (2) to accommodate the 
non-linear relationship with the predictor variables (through 
the link functions) [25]. The logit link function with Gaussian 
family fit the data well, and hence applied in the estimation 
of GLM.
The FRM is a semi-parametric approach, which does not 
make any distributional assumption about an underlying struc-
ture used to obtain the outcome variable, but requires the cor-
rect specification of the conditional mean outcome [26, 27]. 
Given a vector of independent variables (X) and a dependent 
variable (Y), the FRM can be summarized as:
where G(·) is a known nonlinear function satisfying 
0 ≤ G(·) ≤ 1 and β is a vector of parameters to be estimated. 
The complementary log–log (cloglog) is the best alternative 
functional form for G(.) and used as a link function in EQ-
5D-5L prediction.
The zero–one-inflated beta regression is a fully parametric 
regression, which is flexible and capable of modelling depend-
ent variables restricted between 0 and 1 including zero and 
one [28]. As there is no zero response in the present study, a 
one-inflated beta (OIB) regression has been chosen to estimate 
Eq. (1). It estimates the probabilities of having 1 as a separate 
process from values between 0 and 1 [29]. Assuming π1i is the 
probability that individual i is fully healthy (i.e., has observed 
health equal to 1), and π01i = (1 − π1i) is the probability that 
the individual has impaired health (0 < yi < 1) drawn from a 
beta distribution with mean µi, then the overall mean of the 
predicted utility is given by:
The mean response of the continuous beta distribution μi 
and the probability masses of 1 (π1i) were modelled directly 

























where βµ and β1 is a vector of unknown coefficients (includ-
ing constants) to be estimated for the mean of continuous 
beta distribution µi (i.e., for 0 < yi < 1) and the probability 
mass at 1 (i.e., for yi = 1), respectively. The standard beta 
regression and the zero–one-inflated beta regression have 
been detailed elsewhere [28, 30].
In both FRM and OIB, the observed EQ-5D-5L utilities 
were initially normalized onto a 0–1 scale using linear-trans-
formation [20, 31] before entering into the regression as the 
dependent variable. Finally, predicted EQ-5D-5L utilities 
were back-transformed to the original scale.
The MM-estimation is one of the robust regression estima-
tion methods that is used when the distribution of residual is 
not normal or there are some outliers that affect the model [32]. 
The MM-estimation has been described elsewhere [33, 34].
Linear equating
Regression-based mapping models usually produce biased 
predictions due to regression to the mean [11, 12]. Simple lin-
ear equating can reduce this problem [12–14]. Linear equating 
involves a transformation of predicted scores from each of the 
proposed regression models linearly to have the same mean 
and standard deviation as the observed EQ-5D-5L value sets. 
Thus, given observed EQ-5D-5L value set and its predicted 
values (Pred), predicted linear equating  (PredLE) is given by:
 where µObs and σObs were the mean and standard deviation 
of the observed EQ-5D-5L value sets and µPred and σPred 
were the mean and standard deviation of the predicted EQ-
5D-5L value sets obtained from the regression models. Fol-
lowing Hays et al. [13], predictions outside of the observed 
range were constrained to the nearest observed scale.
Predictive accuracy
The predictive performance of each model was assessed by 
the root mean square error (RMSE) and mean absolute error 
(MAE). Since raw values of RMSE and MAE are mislead-
ing to compare datasets and models with different units or 
scales, they are normalized by dividing both RMSE and 
MAE by the range of the observed data. Such normalized 
RMSE (NRMSE) and normalized MAE (NMAE) are non-
dimensional that would allow reasonable comparison across 
models or measures with different scales. Furthermore, the 
performance of each model was assessed by the square of the 
correlation coefficient between the observed and predicted 
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predicted and the observed EQ-5D-5L was also assessed 
using Lin’s concordance correlation coefficient (CCC) [35]. 
Finally, scatter plots between the observed and predicted 
values were reported to visualize the predictive performance 
of each model.
Cross‑validation
The best practice validation should be conducted on a dif-
ferent sample from the one used to generate the regression 
results. In the absence of external data, the second-best 
approach was performing cross-validation by splitting the 
existing data into estimation and validation samples via 
random selection procedures. In this study, the leave-one-
out cross-validation (LOOCV) has been used to evaluate 
the model fit in out-of-sample data. Zhang and Yang [36] 
showed that LOOCV is typically the best modelling proce-
dure in both bias and variance for the predictive performance 
estimation. In LOOCV, the estimation model is trained on all 
the data except for one data point and a prediction is made 
for that point. This procedure has been repeated for all data 
points. The average RMSE, MAE and predicted-r2 (Pred r2) 
from each iteration were calculated for comparison of the 
models’ predictive performance. Pred r2 is a better way to 
validate the predictive ability of the model, particularly in 
predicting future values [40]. All statistical analyses were 
conducted using  Stata® version 16.0 (StataCorp LP, College 
Station, Texas, USA).
Results
The sample characteristics were presented in Table 1. The 
estimated EQ-5D-5L utilities varied in both the mean score 
and the range between the value sets of the two countries. 
In the CHD sample, the mean English EQ-5D-5L value 
set exceeded the US value set by nearly 0.05. Emotional 
subscale was the one with the lowest mean (SD) of 0.683 
(0.192) among MacNew domains. The correlations between 
EQ-5D-5L value sets and MacNew domains were presented 
in Table 2. All MacNew domain scales produced relatively 
high correlation with the EQ-5D-5L value sets (r ≥ 0.63). The 
highest correlation was observed between ‘MacNew Global’ 
and the English value sets: 0.75 (95% CI 0.72–0.78). 
The EFA was appropriate as indicated by a Kai-
ser–Meyer–Olkin (KMO) measure of sampling adequacy 
of 0.845 and a highly significant Bartlett’s Test of Sphe-
ricity ( 2
28
 = 6633.465, p < 0.0001). The EFA produced 
one key factor with meaningful loadings on all MacNew 
domain scales, as well as all the five EQ-5D-5L dimensions. 
This overlap in the same factor suggests that the five EQ-
5D-5L dimensions and the three MacNew domain scales 
would capture a similar latent construct. The result revealed 
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adequate conceptual overlap between the source and target 
instruments such that the mapping algorithm would be valid. 
EFA results were detailed in Table 3 and Fig. 1.
Table 4 presented the performance of models assessed by 
four goodness-of-fit indicators. For both the English and the 
US value sets, OIB regression model consistently performed 
best in terms of all criteria. Interestingly, results from cross-
validation supported the same model. The scatter plot also 
supported this result (Fig. 2). Both GLM and FRM performed 
well following OIB. When the English and the US value sets 
were compared in terms of raw RMSE and MAE, the Eng-
lish value set revealed superior predictive accuracy. However, 
after scale adjustment, both instruments have shown fairly 
similar predictive accuracy (see Fig. 3 and Table 4).  
The predictive accuracy of mapping algorithms at differ-
ent distributions is illustrated in Table 5 (Panel-A). For the 
preferred model, the respective 5th, and 95th percentiles of 
the predicted English value set were 0.48, and 0.96 compared 
with 0.35, and 1 for the observed value set. Similarly, the 5th 
and 95th percentiles of the predicted US EQ-5D-5L value 
set were 0.32, and 0.95 against 0.18, and 1 for the observed 
value set, respectively. These results showed that the best-
fitting model is over-predicting at severe health states and 
under-predicting at better health. Linear equating (reported 
in Panel-B of Table 5) fully eliminated under-prediction of 
high scores and substantially reduced over-prediction of low 
scores.
The best-fitting regression results for both the English 
and the US country-specific value sets were presented in 
Table 6. Except for the social domain scale, other MacNew 
domain scales were significant (p < 0.05) predictors in all 
models. While gender and age were significant (p < 0.05) in 
predicting the continuous beta regression, only gender pre-
dicts the inflation part. The predicted EQ-5D-5L value sets 
from MacNew domain scales can be calculated using the 
results reported in Table 6. First, the mean (μi) for the con-
tinuous beta regression (0 < yi < 1) and the probability mass 
at 1 (π1i) were estimated by applying the logit transformation 
provided in expressions (3a) and (3b), respectively. Then, the 
estimated μi and π1i were applied to Eq. (2) to estimate the 
overall mean of predicted EQ-5D-5L utilities. Finally, the 
predicted EQ-5D-5L utilities would be aligned on the same 
scale as the observed utilities using Eq. (4).
Discussion
The use of the EQ-5D instrument in health economic evalu-
ation has been increasing. However, the generic preference-
based measures in key trials or studies may not be commonly 
used [3]. Thus, there is a need for mapping of disease-spe-
cific instruments onto the preference-based values sets. The 
present study developed mapping functions from the widely 
used CHD rating scale, the MacNew, onto two country-spe-
cific EQ-5D-5L value sets. This enables the potential appli-
cation of these measures to population-based studies and 
economic evaluations.
Table 1  Sample characteristics (n = 943)
SD standard deviation, EQ-5D-5L EuroQol five-dimensional five-
level questionnaire, UK United Kingdom, US United States
Variable Mean (SD)/n (%) Min Max
EQ-5D-5L, mean (SD)
 English 0.804 (0.206) − 0.185 1
 US 0.753 (0.264) − 0.447 1
MacNew domains, mean (SD)
 Emotional 0.683 (0.192) 0.036 1
 Physical 0.716 (0.209) 0.077 1
 Social 0.755 (0.207) 0.064 1
 Global 0.711 (0.183) 0.103 1
Socio-demographics
 Age (in years), mean (SD) 59.760 (13.321) 18 93








Table 2  Correlation coefficients 
between MacNew domain 
scales and EQ-5D-5L value sets
ρ Spearman correlation coefficient, CI bootstrapped confidence interval with 1000 iterations, US United 
States
English value set US value set
ρ 95% CI ρ 95% CI
Lower Upper Lower Upper
Emotional scale 0.681 0.645 0.717 0.627 0.585 0.669
Physical scale 0.724 0.691 0.757 0.726 0.692 0.759
Social scale 0.701 0.666 0.736 0.687 0.650 0.725
Global scale 0.749 0.718 0.779 0.720 0.686 0.755
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The strength of the mapping function depends on the 
degree of conceptual overlap between the descriptive 
systems of the source and target instruments [3, 11]. The 
result revealed adequate conceptual overlap between the 
source and target instruments such that the mapping algo-
rithm would be valid. However, the three MacNew domain 
scales are overlapping. For instance, emotional and physical 
domain scales include items relating to social interaction. 
The social domain contains all social items but also items 
relating to physical mobility and self-esteem. Consequently, 
the social functioning domain has shown either statistically 
insignificant estimates or logically inconsistent signs in the 
estimated coefficients for the prediction of both the English 
and the US EQ-5D-5L value sets.
In this mapping study, the merits of five regression mod-
els have been examined based on four goodness-of-fit crite-
ria. OIB regression consistently performed best in predicting 
EQ-5D-5L utilities. Interestingly, the beta-binomial regres-
sion model performed best in predicting EQ-5D utilities in 
several other mapping studies [4, 37–39]. GLM generally 
produced the second-best on nearly all criteria, except MAE 
for the US value set where MM-estimator is the second-best. 
Essentially, GLM and OIB equally performed well on both 
CCC and r2 in predicting the English value set. FRM and 
GLM performed quite similar in the prediction of the US 
vale set. The novelty of the FRM and the OIB model is that 
they are more appropriate for data that is bounded and they 
accounted for the nonlinearity in the data.
Table 3  Exploratory factor analysis for the MacNew domain scales 
and EQ-5D-5L dimensions: iterated principal factor
EQ-5D-5L EuroQol five-dimensional five-level questionnaire, Mac-
New MacNew Heart Disease Quality of life Questionnaire
Factor Eigenvalue Difference Proportion Cumulative
Panel-A: unrotated factor loadings
Factor1 4.669 4.054 1.000 1.000
Factor2 0.615 0.468 0.132 1.132
Factor3 0.147 0.170 0.032 1.163
Factor4 − 0.023 0.101 − 0.005 1.158
Factor5 − 0.125 0.019 − 0.027 1.132
Factor6 − 0.144 0.030 − 0.031 1.101
Factor7 − 0.174 0.123 − 0.037 1.064
Factor8 − 0.297 − 0.064 1.000
Variable Factor 1 Uniqueness
Panel-B: rotated factor matrix
MacNew domain scales
 MacNew emotional 0.793 0.371
 MacNew physical 0.904 0.183




 Usual activities 0.801 0.359
 Pain/discomfort 0.705 0.503
 Anxiety/depression 0.610 0.627
Fig. 1  A scree plot showing the 
results of the iterated princi-
pal factor with one true factor 
underlying eight variables
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Fig. 2  Scatter plots of observed vs predicted EQ-5D-5L value sets. OLS ordinary least square, GLM generalized linear model, FRM fractional 
regression model, OIB one-inflated beta regression. Broken line is a line along which observed and predicted value sets are equal
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A recent study by Chen et al. [2] has published mapping 
functions from MacNew onto six preference-based instruments 
including the EQ-5D using the same data set, which differs in 
several important aspects from the current study. The study by 
Chen and colleagues only considered three regression models 
(OLS, GLM and MM). The present study, however, consid-
ered two more analytical approaches, addressing the charac-
teristics of the data such as problems of normality and non-
linearity. Most importantly, while the present study employed 
the directly elicited EQ-5D-5L value sets, the study by Chen 
and colleagues used the interim value set, which was a “cross-
walk” between the earlier three-level EQ-5D value set and the 
EQ-5D-5L descriptive system [10]. Therefore, the preferred 
models and their performance in terms of goodness-of-fit cri-
teria were quite different. For instance, the preferred model 
for the English value set in this study produced RMSE, MAE, 
CCC, and  r2 values of 0.1323, 0.0901, 0.7680 and 0.5909, 
respectively. In the study by Chen and colleagues, the preferred 
model for predicting EQ-5D was OLS; and MAE (0.1117), 
intraclass correlation (0.827) and r2 (0.552) were reported as 
Fig. 3  Scatter plot of predicted vs observed EQ-5D-5L value sets for 
the preferred model: upper panel for the English value set and lower 
panel for the US value set. NB: red line depicts reduced major axis 
(RMA) line, which shows a measure of the centre of the data; bro-
ken blue line is a line along which observed value sets equal pre-
dicted utilities. Perfect prediction occurs when RMA line and the line 
of perfect concordance overlaps. US United States, OIB one-inflated 
beta regression
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goodness-of-fit criteria. In general, the discrepancy observed 
between the two studies may partly be attributable to differ-
ences in the target instrument used and partly due to the map-
ping functions employed, as well as variations in the additional 
covariates applied in predicting EQ-5D-5L utility values.
Mapping algorithms generally suffer from over-predic-
tion for respondents in poor health and under-prediction for 
respondents in better health, mainly because of regression 
to the mean [11]. This phenomenon is detailed in Table 5, 
Panel-A. Linear equating can reduce the typical problem of 
under-prediction of high scores and over-prediction of low 
scores [12]. With linear equating, the smallest predicted val-
ues considerably dropped for both the English and the US 
value sets (see Table 5, Panel-B). Yet, there is an overestima-
tion of scores for less than the  10th percentile of the EQ-5D-5L 
value sets. This may be attributable to the strong decrements 
of preference weights of the EQ-5D-5L at severe health states 
only with few observations. Nevertheless, there is clearly an 
improved predictive accuracy after linear equating. In addition 
to mean values, linear equating forces the predicted values to 
have the same standard deviation as observed values, result-
ing in similar variability between the estimated values for the 
linear equating models and the observed values [14].
The present study has assessed the mapping functions for 
two different EQ-5D-5L value sets against MacNew scale. 
Clearly, different EQ-5D-5L value sets produce different 
utility scores, especially at the lower end. For instance, the 
observed scale in the current dataset is 1.185 (i.e., − 0.185 to 
1) for the English value set, and 1.447 (i.e., − 0.447 to1) for 
the US value set. Therefore, the country-specific mapping 
function could be a better option to reflect the preference 
from a particular country. Considering the scale differences 
between the two countries’ value sets, the scale adjusted 
RMSE and MAE are also reported. The results are quite 
similar for the two countries, though the English value set 
has shown slightly better predictive ability in terms of both 
NRMSE and NMAE (Table 4). In contrast, the US value 
set slightly outperformed in terms of both CCC and r2. 
Such differences are expected, because of cultural as well 
as methodological variations. Although both value sets fol-
lowed EQ-VT approach, the English value set is a hybrid-
based that combines composite time-trade-off (cTTO) and 
discrete choice experiment (DCE), and the US value set is 
cTTO-based.
This study has a number of strengths. First, several 
mapping functions have been investigated, among which 
the OIB outperformed the rest. The OIB model has the 
ability to predict within the given range and allows a non-
linear relationship between the dependent and predictor 
variables. Secondly, the predicted-r2 helps identify where 
the model provides a good fit for the existing data; more 
importantly, it also indicates how a regression model 
predicts responses for the new dataset [40]. Another key 
advantage of predicted r2 is its ability to prevent overfitting 
of a model. The wider the gap between conventional r2 and 
predicted-r2, the stronger is the problem of overfitting. In 
this study, the discrepancy between the predicted-r2 and 
the conventional r2 is trivial, indicating a good model fit. 
Thus, future mapping studies are encouraged to report 
predicted-r2 in cross-validation of the predictive accu-
racy of models. Thirdly, the application of linear equating 
minimizes mapping bias due to regression to the mean, 
which is a novel approach to align two measures on the 
same scale. Because the objective of this study was to map 
MacNew domain scales to the equivalent EQ-5D-5L value 
sets, predicted EQ-5D-5L value sets from each regression 
model were transformed linearly to have the same mean 
and standard deviation as the observed EQ-5D-5L value 
sets. Therefore, linking methods provide accurate pre-
diction, particularly at the group level, which is the case 
in most economic evaluations that apply QALYs. Such 
linking produces the preference-based value sets that are 
equivalent to the condition- or disease-specific scores by 
aligning the score distributions of the two on similar scales 
[12]. In vein with other studies [13, 14, 29], the estimated 
EQ-5D-5L scores should be used only for group-level (not 
for the individual level) analysis.
With regard to study limitations, self-selection bias 
might have occurred, as respondents were volunteered to 
participate in the online survey. As generalizability is a 
major issue for mapping studies, the proposed mapping 
Table 6  Regression results predicting EQ-5D-5L from MacNew sub-
scales for the preferred model: OIB
In each model, EQ-5D-5L was a target or dependent variable. Robust 
standard errors in parentheses
OIB one-inflated beta regression, EQ-5D-5L EuroQol five-dimen-
sional five-level questionnaire, MacNew MacNew Heart Disease 
Quality of life Questionnaire, β estimated coefficients, SE standard 
errors for β
***p < 0.01, **p < 0.05, *p < 0.1
Variables English US
β (SE) β (SE)
Beta regression
Emotional 1.876*** (0.199) 1.591*** (0.218)
Physical 2.176*** (0.172) 2.626*** (0.193)
Female − 0.095** (0.043) − 0.107** (0.048)
Age (in years) − 0.008*** (0.002) − 0.011*** (0.002)
Constant − 0.552*** (0.161) − 0.499*** (0.174)
One-inflate
Emotional 4.437*** (1.070) 4.437*** (1.070)
Physical 7.592*** (1.471) 7.592*** (1.471)
Female − 0.496** (0.242) − 0.496** (0.242)
Constant − 10.802*** (1.094) − 10.802*** (1.093)
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function should be tested on how the model performs in 
different CHD patient populations.
In conclusion, this study has developed a set of mapping 
algorithms to predict EQ-5D-5L value sets from the MacNew 
domain scales. Thus, in the absence of generic preference-
based value sets, the preferred mapping model can adequately 
convert disease-specific scores onto a generic outcome metric 
like QALYs, which facilitates economic evaluations of CHD 
health interventions. The linear equating model may provide 
more accurate estimates of EQ-5D-5L utility values.
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